Malignant melanoma arising from nevi, p53, p16, and Bcl-2: expression in benign versus malignant components
Market Dynamics: Restraints High cost of medications High cost of medications The high cost of glucagon-like peptide 1 (GLP-1) analogues serves as a significant constraint in the global market for these medications
Nat Rev Dis Primers 2:16003 Shamloul R, Ghanem H (2013) Erectile dysfunction
But at 104 degrees Fahrenheit, that same level of degradation can happen in a fraction of the time
On the other hand, researchers have claimed that given the cost of these drugs, if only 10% of overweight Medicare patients filled branded products, it would cost Medicare $26.8B a year
Most adverse events reflect expected pharmacology interacting with patient context